Concepedia

Early Toxicity Recognition

Early Toxicity Recognition is a clinical monitoring framework designed to identify and characterize immune-related adverse events promptly following the initiation of immune checkpoint inhibitor therapy.

65

Publications

3.8K

Citations

561

Authors

215

Institutions

Publications per year

2017–2026

38

Parents

Publications

65

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

Michael J. Zeléfsky, Zvi Fuks, Margie Hunt et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 775 citations

, , +17

Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities

Salahaldin A. Tahir, Jianjun Gao, Yuji Miura et al. · Proceedings of the National Academy of Sciences · 2019 · 241 citations · Full text

, , +17

Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib

Bruno Vincenzi, Daniele Santini, Antonio Russo et al. · The Oncologist · 2010 · 176 citations · Full text

, , +16

Proton Versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity

James B. Yu, Pamela R. Soulos, Jeph Herrin et al. · JNCI Journal of the National Cancer Institute · 2012 · 173 citations · Full text

, , +17

Cancer Immunotherapy: Imaging Assessment of Novel Treatment Response Patterns and Immune-related Adverse Events

Jennifer Kwak, Sree Harsha Tirumani, Annick D. Van den Abbeele et al. · Radiographics · 2015 · 168 citations

, , +17

1–5 of 65

Authors

561

  1. JG
    Jianjun Gao

    The University of Texas MD Anderson Cancer Center, United States

    3 publications · 321 citations

    3

    h-index

  2. CC
    Cielito C. Reyes‐Gibby

    The University of Texas MD Anderson Cancer Center, United States

    2 publications · 117 citations

    2

    h-index

  3. YY
    Yoshiya Yamada

    Memorial Sloan Kettering Cancer Center, United States

    2 publications · 832 citations

    2

    h-index

  4. RF
    Rainer Fietkau

    Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

    2 publications · 129 citations

    2

    h-index

  5. SK
    Sumit K. Subudhi

    The University of Texas MD Anderson Cancer Center, United States

    2 publications · 276 citations

    2

    h-index

1–5 of 561

Institutions

215

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    6 h-index

    68 publications

    5K citations

  2. Brigham and Women's Hospital

    Boston, United States

    4 h-index

    14 publications

    498 citations

  3. Memorial Sloan Kettering Cancer Center

    New York, United States

    3 h-index

    23 publications

    7.9K citations

  4. Universitätsklinikum Erlangen

    Erlangen, Germany

    3 h-index

    22 publications

    678 citations

  5. Harvard University

    Cambridge, United States

    3 h-index

    12 publications

    361 citations

  6. Friedrich-Alexander-Universität Erlangen-Nürnberg

    Erlangen, Germany

    3 h-index

    21 publications

    660 citations

  7. University of Wisconsin–Madison

    Madison, United States

    3 h-index

    4 publications

    207 citations

  8. Inserm

    Paris, France

    3 h-index

    11 publications

    310 citations

1–8 of 215

Venues

  1. 8

    h-index

  2. Radiotherapy and Oncology

    3 publications · 313 citations

    3

    h-index

  3. Frontiers in Oncology

    2 publications · 35 citations

    2

    h-index

  4. PubMed

    Repository · 2 publications · 48 citations

    2

    h-index

  5. Current Oncology

    2 publications · 27 citations

    2

    h-index

1–5